Fidelity Investments buys a big stake in Abiomed

November 11, 2009 by MassDevice staff

The mutual fund company snapped up 2.3 million shares between July and September and now controls 12.7 percent of the Danvers, Mass.-based cardiac assist device maker.

Fidelity Investments buys a big stake in Abiomed

Fidelity Investments is taking a shine to Abiomed Inc. (ABMD) stock again.

Portfolio managers with the Boston-based mutual-fund giant have been big buyers of Abiomed stock this year, purchasing over 2.35 million shares of the Danvers, Mass.-based device maker during the three months ended Sept. 30. That follows a 2.1-million-share buying spree during the prior quarter, boosting the funds' overall stake to 4.75 million shares, according to new stock ownership reports.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.